0001179110-12-013923.txt : 20120911 0001179110-12-013923.hdr.sgml : 20120911 20120911201938 ACCESSION NUMBER: 0001179110-12-013923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120907 FILED AS OF DATE: 20120911 DATE AS OF CHANGE: 20120911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHEMA SUZANNE M CENTRAL INDEX KEY: 0001225509 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 121086573 MAIL ADDRESS: STREET 1: C/O ZYMOGENETICS, INC. STREET 2: 1201 EASTLAKE AVENUE CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2012-09-07 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001225509 SHEMA SUZANNE M C/O ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, GC and Corp. Secretary Common Stock 2012-09-07 4 M 0 656 30.28 A 43053 D Common Stock 2012-09-07 4 M 0 1345 32.07 A 44398 D Common Stock 2012-09-07 4 S 0 2001 77.88 D 42397 D Stock Option (Right to Buy) 30.28 2012-09-07 4 M 0 656 0.00 D 2020-03-30 Common Stock 656 12469 D Stock Option (Right to Buy) 32.07 2012-09-07 4 M 0 1345 0.00 D 2019-08-31 Common Stock 1345 27564 D Shares sold pursuant to 10b5-1 plan. 12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercibale in equal monthly installments over the following 42 months for a total vesting of 48 months. Twenty-five percent of the shares subject to the option vest and become exercisable one year from the date of grant and vest and become exercisable at a rate of 1/48th per month thereafter. /s/ Warren DeSouza, Attorney-in-fact 2012-09-11